Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT00324779 · COMPLETED
Trial details
- NCT number
- NCT00324779
- Sponsor
- University Hospital Erlangen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2011-04-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.